Table 4.
Characteristics of atrial fibrillation registries involving sites in China
| Studies | Countries | Sites | Population | Sample size | QI measure | Follow-up | Study period |
| Sun et al 28 | China only | 50 | Outpatient | 3017 | No | No | 2012 |
| CAFR12 | China only | 32 | Outpatient/inpatient | 11 496 | No | Up to 2020 | 2011–present |
| GLORIA-AF II31 | 42 | 736 | Outpatient | 10 871 | No | 2 year | 2011–present |
| Nanchang AF Project13 | China only | 1 | Inpatient | 2442 | No | No | 2011–2013 |
| GARFIELD-AF30 | 30 | 858 | Outpatient/inpatient | 17 184 | No | 1 year | 2010–2013 |
| Chinese AF registry10 | China only | 20 | Emergency department | 2016 | No | 1 year | 2008–2011 |
| Sun et al 29 | China only | 18 | Inpatient | 3425 | No | No | 2000–2004 |
CAFR, Chinese Atrial Fibrillation Registry Study; GARFIELD-AF, Global Anticoagulant Registry in the FIELD-Atrial Fibrillation; GLORIA-AF, Global Registry on Long-term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation; QI, quality improvement.